These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 17218063)
41. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Olechowski CJ; Truong JJ; Kerr BJ Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337 [TBL] [Abstract][Full Text] [Related]
42. Neuropathic pain and temporal expression of preprodynorphin, protein kinase C and N-methyl-D-aspartate receptor subunits after spinal cord injury. Labombarda F; Coronel MF; Villar MJ; Nicola AF; González SL Neurosci Lett; 2008 Dec; 447(2-3):115-9. PubMed ID: 18835424 [TBL] [Abstract][Full Text] [Related]
43. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Mika J; Osikowicz M; Makuch W; Przewlocka B Eur J Pharmacol; 2007 Apr; 560(2-3):142-9. PubMed ID: 17307159 [TBL] [Abstract][Full Text] [Related]
45. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421 [TBL] [Abstract][Full Text] [Related]
46. Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy. Sacerdote P; Franchi S; Trovato AE; Valsecchi AE; Panerai AE; Colleoni M Neurosci Lett; 2008 May; 436(2):210-3. PubMed ID: 18394803 [TBL] [Abstract][Full Text] [Related]
47. Repeated administration of mirtazapine inhibits development of hyperalgesia/allodynia and activation of NF-kappaB in a rat model of neuropathic pain. Zhu J; Wei X; Feng X; Song J; Hu Y; Xu J Neurosci Lett; 2008 Mar; 433(1):33-7. PubMed ID: 18248895 [TBL] [Abstract][Full Text] [Related]
48. Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A. Chuang YC; Yoshimura N; Wu M; Huang CC; Chiang PH; Tyagi P; Chancellor MB Eur Urol; 2007 Apr; 51(4):1119-27. PubMed ID: 17141941 [TBL] [Abstract][Full Text] [Related]
49. Intravenous mononuclear marrow cells reverse neuropathic pain from experimental mononeuropathy. Klass M; Gavrikov V; Drury D; Stewart B; Hunter S; Denson DD; Hord A; Csete M Anesth Analg; 2007 Apr; 104(4):944-8. PubMed ID: 17377111 [TBL] [Abstract][Full Text] [Related]
50. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. Mika J; Wawrzczak-Bargiela A; Osikowicz M; Makuch W; Przewlocka B Brain Behav Immun; 2009 Jan; 23(1):75-84. PubMed ID: 18684397 [TBL] [Abstract][Full Text] [Related]
51. A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice. Fuccio C; Luongo C; Capodanno P; Giordano C; Scafuro MA; Siniscalco D; Lettieri B; Rossi F; Maione S; Berrino L Eur J Pharmacol; 2009 Jan; 603(1-3):42-9. PubMed ID: 19100257 [TBL] [Abstract][Full Text] [Related]
52. Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature. Oeconomou A; Madersbacher H; Kiss G; Berger TJ; Melekos M; Rehder P Eur Urol; 2008 Oct; 54(4):765-75. PubMed ID: 18571306 [TBL] [Abstract][Full Text] [Related]
53. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice. Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867 [TBL] [Abstract][Full Text] [Related]
54. Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain. Guneli E; Karabay Yavasoglu NU; Apaydin S; Uyar M; Uyar M Pharmacol Biochem Behav; 2007 Nov; 88(1):9-17. PubMed ID: 17651791 [TBL] [Abstract][Full Text] [Related]
55. Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice. Matak I; Tékus V; Bölcskei K; Lacković Z; Helyes Z Neuroscience; 2017 Sep; 358():137-145. PubMed ID: 28673722 [TBL] [Abstract][Full Text] [Related]
56. Dynamic mechanical allodynia in neuropathic pain. Bowsher D Pain; 2005 Jul; 116(1-2):164-5. PubMed ID: 15927381 [TBL] [Abstract][Full Text] [Related]
57. Pain behavior measures to quantitate joint pain and response to neurotoxin treatment in murine models of arthritis. Krug HE; Frizelle S; McGarraugh P; Mahowald ML Pain Med; 2009 Oct; 10(7):1218-28. PubMed ID: 19818032 [TBL] [Abstract][Full Text] [Related]
58. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia. Klein T; Magerl W; Hanschmann A; Althaus M; Treede RD Eur J Pain; 2008 Jan; 12(1):17-29. PubMed ID: 17449306 [TBL] [Abstract][Full Text] [Related]
59. Differential regulation of TRP channels in a rat model of neuropathic pain. Staaf S; Oerther S; Lucas G; Mattsson JP; Ernfors P Pain; 2009 Jul; 144(1-2):187-99. PubMed ID: 19446956 [TBL] [Abstract][Full Text] [Related]
60. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence. Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]